Cross Cancer Institute | Oncology

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 1 studies all time

What they study most

Cancer

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling